Delivery Order SPE2DB22D9133-SPE2DB24FYV27
Award Date 10/26/23
Potential Completion Date 11/17/23
Potential Value $5.8K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency to provide Actemra Actpen 162 mg/0.9 ml prefilled syringes. The $5,776 delivery order has a completion date of November 28, 2023 and was awarded on November 3, 2023. DMS Pharmaceutical Group will supply the pharmaceutical items to DLA Troop Support Medical facilities from its location in Park Ridge, Illinois. As a woman-owned small...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency to provide Actemra Actpen 162 mg/0.9 ml prefilled syringes. The $5,776 delivery order has a completion date of January 9, 2024 and was awarded on December 15, 2023. DMS Pharmaceutical Group will supply the pharmaceutical items to DLA Troop Support Medical facilities from its location in Park Ridge, Illinois. As a woman-owned small business,...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide Actemra Actpen 162 mg/0.9 ml syringes. The $2,923.36 order has a completion date of February 2, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds various federal contracts and indefinite delivery vehicles with DLA to supply pharmaceuticals and medical products to military treatment facilities worldwide. This...
- The U.S. Defense Logistics Agency has awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide Actemra Actpen 162 mg/0.9 ml medication. The contract, valued at $6,577.56, has a completion date of February 21, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler based in Park Ridge, Illinois and holds a larger indefinite delivery contract with DLA valued up to $4,999,999 through 2025 for a broad range of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth up to $4,385.04 to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business located in Park Ridge, Illinois. The contract, which has no set-aside designation, is for the delivery of 4564299269 - Actemra Actpen 162 mg/0.9 ml 0.9ml syringes. This delivery order is part of a larger indefinite delivery contract (SPE2DB24FYW67) between DMS Pharmaceutical Group and DLA, valued at up to...
- The Defense Logistics Agency awarded a delivery order valued at $3,685.98 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Actemra Actpen 162 mg/0.9 mL prefilled syringes. The award, issued on October 16, 2025, with an ultimate completion date of November 6, 2025, utilizes firm fixed-price pricing and carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency valued at $9,273.12 for the supply of Actemra Actpen 162 mg/0.9 ml injection pens. The award, issued on May 12, 2025, with an ultimate completion date of June 3, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's significant Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $9,273.12 to DMS Pharmaceutical Group Inc. for the supply of Actemra Actpen 162 mg/0.9 ml injections. The contract, issued on June 4, 2025, with an ultimate completion date of June 26, 2025, represents a standard procurement action with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform the delivery...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The order is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a pharmaceutical product, with a potential value of $2,923.36 and a completion date of February 2, 2024. This delivery order is part of a larger indefinite delivery contract that DMS Pharmaceutical Group holds with DLA to provide a variety of pharmaceutical and medical supplies,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,182.08 fixed-price contract is for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialized pharmaceutical product, with a period of performance through January 30, 2025. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the...